Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03062085 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Shanghai High Myopia Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2030 to Dec 31, 2035
    • Study completion date: Dec 31, 2040 to Dec 31, 2045
    v8
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Dec 31, 2025 to Dec 31, 2030
    • Study completion date: Dec 31, 2025 to Dec 31, 2040
    v6
  4. 3 versions Re-verified since Oct 1, 2019, no change to tracked fieldsv3-v5
  5. Secondary endpoint revised
    • Study description expanded, about 4 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract and age-related cataract patients. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of high myopic cataract.
Trial Details
NCT Number NCT03062085
Lead Sponsor Shanghai High Myopia Study Group
Collaborators: Eye & ENT Hospital of Fudan University
Conditions
(from sponsor)		 High Myopia, Cataract, Visual Outcome, Genetic Anticipation
Related terms Anticipation, Genetic, Cataract
Enrollment 60,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov